| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/16/2007 | EP0989853B1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 05/16/2007 | EP0930894B1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 05/16/2007 | CN1964741A Methods of using molecules related to organic cation transporter 3 (OCT3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 05/16/2007 | CN1964720A Transgenic models of alzheimer's disease and uses therefor in the treatment of a variety of neurodegenerative diseases |
| 05/16/2007 | CN1964630A Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 05/16/2007 | CN1962872A Ribozyme specific for cutting vessel endothelium growth factor RNA and use thereof |
| 05/16/2007 | CN1962864A Small-interfering RNA inhibiting gene expression of GATA-3 and its coding gene and use |
| 05/16/2007 | CN1962863A PEG10-siRNA inhibiting gene expression of human PEG10 and its pharmaceutical use |
| 05/16/2007 | CN1961961A A pharmaceutical formulation and preparation process thereof |
| 05/16/2007 | CN1316022C Novel chimeric TNF ligands |
| 05/16/2007 | CN1315537C LIM Mineralization protein splice variants |
| 05/16/2007 | CN1315535C Adjuvant for improving hepatitis B vaccine immune effect and preparing method thereof |
| 05/15/2007 | US7219253 Process for providing submodel performance in a computer processing unit |
| 05/15/2007 | US7217811 Human gene critical to fertility |
| 05/15/2007 | US7217795 Tumor suppressor designated TS10q23.3 |
| 05/15/2007 | US7217700 Chemokines as adjuvants of immune response |
| 05/15/2007 | US7217699 Compositions comprising genome segments and methods of using the same |
| 05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
| 05/15/2007 | US7217687 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 05/15/2007 | US7217555 isolated human NAALAD-ase (N-acetylated alpha-linked acidic dipeptidases) L protein; |
| 05/15/2007 | US7217524 Method for diagnosing aplasia of corpus callosum |
| 05/15/2007 | CA2324649C Human p51 genes and gene products thereof |
| 05/15/2007 | CA2294337C Preparation of pharmaceutical compositions |
| 05/15/2007 | CA2255540C Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/15/2007 | CA2149922C Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 05/15/2007 | CA2094705C Pharmaceutical composition for treating or preventing malign tumors |
| 05/10/2007 | WO2007053803A2 Antagonist of teb4 and methods of use |
| 05/10/2007 | WO2007053802A2 Drug and gene delivery by polymer nanonozzle and nanotip cell patch |
| 05/10/2007 | WO2007053696A2 Rnai inhibition of influenza virus replication |
| 05/10/2007 | WO2007053565A2 Novel a-galactosidases |
| 05/10/2007 | WO2007052728A1 Method for improvement in transformation efficiency or homologous recombination efficiency in cell by using dna oligomer as carrier for gene delivery, and cell transformed using the method |
| 05/10/2007 | WO2007052029A1 Oncolytic herpes virus vectors |
| 05/10/2007 | WO2007051898A1 Alternative oxidase and uses thereof |
| 05/10/2007 | WO2007051316A1 Inhibition of autophagy genes in cancer chemotherapy |
| 05/10/2007 | WO2007051267A2 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions |
| 05/10/2007 | WO2007035962A3 Gene blocking method |
| 05/10/2007 | WO2007023479A3 Treatment of central nervous system injury |
| 05/10/2007 | WO2006126982A3 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 05/10/2007 | WO2006101503A3 Method for screening agents against human prostate disease |
| 05/10/2007 | WO2006036173A3 Frizzled proteins and detection and treatment of cancer |
| 05/10/2007 | WO2004060910A3 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 05/10/2007 | US20070107073 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 05/10/2007 | US20070107071 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 05/10/2007 | US20070105809 Modulators of coagulation factors with enhanced stability |
| 05/10/2007 | US20070105808 Inhibition of histone deacetylase |
| 05/10/2007 | US20070105807 capable of altering the splicing of a pre-mRNA encoding said receptor to increase production of a stable, secreted, ligand-binding form of the receptor; arthritis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel disease, hepatitis, sepsis |
| 05/10/2007 | US20070105806 Administering to a patient in needs of treatment, prevention or management of neuropathic pain, a therapeutically or prophylactically effective amount of a double-stranded RNA (dsRNA), consists of a sense strand and an antisense strand that are complementary to each other |
| 05/10/2007 | US20070105805 guanidine-rich oligonucleotides to disrupt disease-causing protein aggregates (Huntington's Disease (HD) protein aggregates) |
| 05/10/2007 | US20070105804 Drug delivery of polynucleotide to primate hepatocyte; high level of gene expression with transient increases in liver enzymes |
| 05/10/2007 | US20070105803 Methods and compositions for treating neurological disease |
| 05/10/2007 | US20070105802 Compositions and methods for modulating and monitoring neurotransmitter receptor populations |
| 05/10/2007 | US20070105800 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 05/10/2007 | US20070105799 Codon-optimized polynucleotide-based vaccines against Bacillus anthracis infection |
| 05/10/2007 | US20070105798 Method of Converting Base in DNA Sequence |
| 05/10/2007 | US20070105797 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 05/10/2007 | US20070105796 Method for inhibiting telomerase activity and inhibitor thereof |
| 05/10/2007 | US20070105795 Gene expression suppression agents |
| 05/10/2007 | US20070105794 Immunotherapy |
| 05/10/2007 | US20070105765 Compositions comprising a fragment of the herpesviral protein vp22 for delivery of substances to cells |
| 05/10/2007 | US20070105764 Fusion protein for controlling production of proteins in bioreactor: cellular therapy (somatic gene therapy); antiviral therapies |
| 05/10/2007 | US20070105752 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070105109 Sirt1 and genetic disorders |
| 05/10/2007 | US20070105104 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4) |
| 05/10/2007 | US20070105102 Method for detection and characterization of pre-malignant transformation |
| 05/10/2007 | US20070104783 Double-Layered Absorbable Solid Compositions for the Topical Treatment of Oral Mucosal Disorders |
| 05/10/2007 | US20070104776 Drug having regulatory cell ligand contained in liposome |
| 05/10/2007 | US20070104775 Amphoteric liposomes |
| 05/10/2007 | US20070104736 Culturing a non-typeable Haemophilus influenzae strain having a mutation in htrB gene, wherein the htrB mutation produces a mutant non-typeable Haemophilus influenzae; purifying the mutant endotoxin |
| 05/10/2007 | US20070104732 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/10/2007 | US20070104726 Multimeric complexes of antigens and adjuvants |
| 05/10/2007 | US20070104723 Treatment of fibrotic disease |
| 05/10/2007 | US20070104716 Methods for controlling pathological angiogenesis by inhibition of a6b4 integrin |
| 05/10/2007 | US20070104699 Compositions for and methods of granzyme B inhibition |
| 05/10/2007 | US20070104698 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 05/10/2007 | US20070104697 Treatment of neural injury and neurodegenerative diseases by administering adipose tissue-derived stromal cells; stroke, traumatic brain injury, spinal cord injury and Parkinson's disease; inducing neurorestorative pathways in the brain; activating the neural cell differentiation in an injured brain |
| 05/10/2007 | US20070104696 Use of cell lines to produce active therapeutic proteins |
| 05/10/2007 | US20070104690 Retroviral vectors |
| 05/10/2007 | US20070104689 Compositions and methods for treating tumors presenting survivin antigens |
| 05/10/2007 | US20070104688 Small interfering RNA mediated transcriptional gene silencing in mammalian cells |
| 05/10/2007 | US20070104687 AAV vectors for in vivo gene therapy of rheumatoid arthritis |
| 05/10/2007 | US20070104686 Vaccines, immunotherapeutics and methods for using the same |
| 05/10/2007 | US20070104685 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 05/10/2007 | US20070104684 Ocular gene therapy |
| 05/10/2007 | US20070104654 For delivery of water insoluble drugs, growth factors, genes, or cosmetic substances; biocompatible and biodegradable |
| 05/10/2007 | CA2628477A1 Inhibition of autophagy genes in cancer chemotherapy |
| 05/10/2007 | CA2610265A1 Methods for producing micrornas |
| 05/09/2007 | EP1783228A1 Recombinant expression of multiprotein complexes using polygenes |
| 05/09/2007 | EP1783226A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783225A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783224A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/09/2007 | EP1783216A1 Telomerase-inhibitory ena oligonucleotide |
| 05/09/2007 | EP1783215A1 Angiostatin and method of use for inhibition of angiogenesis |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1782838A1 Inhibition of infiltration, and cell killing agent |
| 05/09/2007 | EP1782821A1 Drug and method for improving brain function |
| 05/09/2007 | EP1781788A2 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 05/09/2007 | EP1781593A2 Cationic lipids and methods of use |